Department of Health and Human Services$1.1M obligationsEnds Dec 18, 2021
Federal contract award
HHSN27500003
IGF::OT::IGF TITLE: CLINICAL EVALUATION OF NOVEL PRODUCTS FOR FEMALE CONTRACEPTION, MAIN STUDY EFFECTIVE DATE: 9/19/2014 PERIOD OF PERFORMANCE: 9/19/2014-9/18/2017
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NICHD |
| NAICS | 541712 |
| PSC | AN11 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH |
| Parent award / vehicle | HHSN275201300022I |
| Set-aside | Not reported |
| Pricing type | COST NO FEE |
| Obligations | $743.4K |
| Current contract value | $743.4K |
| Potential contract value / ceiling | $743.4K |
| Start date | Sep 19, 2014 |
| Current end date | Jan 31, 2022 |
| Potential end date | Jan 31, 2022 |
| Latest award activity | Aug 27, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 8 of 8 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Aug 27, 2026 | P00007 | $-0 | NICHD: R&D: CLINICAL EVALUATION OF NOVEL PRODUCTS FOR FEMALE CONTRACEPTION, MAIN STUDY: NON-SEVERABLE |
| Dec 30, 2021 | P00006 | $0 | CLINICAL EVALUATION OF NOVEL PRODUCTS FOR FEMALE CONTRACEPTION, MAIN STUDY |
| Sep 28, 2021 | P00005 | $6.8K | CLINICAL EVALUATION OF NOVEL PRODUCTS FOR FEMALE CONTRACEPTION, MAIN STUDY |
| Dec 23, 2020 | P00004 | $45.9K | CLINICAL EVALUATION OF NOVEL PRODUCTS FOR FEMALE CONTRACEPTION |
| Jun 11, 2020 | P00003 | $129.5K | CLINICAL EVALUATION OF NOVEL PRODUCTS FOR FEMALE CONTRACEPTION, MAIN STUDY |
| Aug 8, 2019 | P00002 | $251.6K | CLINICAL EVALUATION OF NOVEL PRODUCTS FOR FEMALE CONTRACEPTION, MAIN STUDY |
| Sep 19, 2017 | 1 | $0 | IGF::OT::IGF TITLE: CLINICAL EVALUATION OF NOVEL PRODUCTS FOR FEMALE CONTRACEPTION, MAIN STUDY EFFECTIVE DATE: 9/19/2014 PERIOD OF PERFORMANCE: 9/19/2014-9/18/2017 |
| Sep 19, 2014 | 0 | $309.5K | IGF::OT::IGF TITLE: CLINICAL EVALUATION OF NOVEL PRODUCTS FOR FEMALE CONTRACEPTION, MAIN STUDY EFFECTIVE DATE: 9/19/2014 PERIOD OF PERFORMANCE: 9/19/2014-9/18/2017 |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.